期刊
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
卷 14, 期 3, 页码 759-768出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.nano.2018.01.005
关键词
Dendrimer; Doxorubicin; Drug delivery; Iron oxide nanoparticles; Magnetic drug targeting; Syngeneic allograft; Tumor regression
资金
- Nanomission, Department of Science and Technology, Government of India
- TATA Centre for Technology and Design (TCTD), IIT Bombay
This work evaluates the magnetically-guided delivery of DOX-loaded dendritic-Fe3O4 nanoparticles and their tumor regression efficacy in subcutaneous melanoma in C57BL/6 mice. The hematological, biochemical and histopathological parameters were minimally affected. The nanoparticles localized in lungs, liver and spleen suggesting non-specific uptake. However, in tumor-bearing mice, substantially higher localization in magnetically-targeted tumor was observed when compared to passive localization in non-targeted tumor. The animals of treated group showed significantly high iron levels (161 mu g of Fe/mg dry organ weight) in the tumor against the control (<25 mu g of Fe/mg dry organ weight). This high localization led to high concentrations of DOX in the tumor which not only induced significant tumor regression but also arrested further growth. Within 14 days, the average tumor volume was reduced to 55 +/- 8.3 mm(3) (treated) as compared to 4794 +/- 844 mm(3) (control), i.e. similar to 88-fold decrease. The tumor disappeared by the end of 20th day post-treatment and similar to 100% survival rate was observed. (c) 2018 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据